Afrezza was supposed to be clearly superior and the other competitors were supposed to not really even be competitors because of the inhaler being so different and so preferred over needles. At least that's what people on this board were saying when it was approved.
Your making the same argument as to TrepT that people on this board were making when afrezza was approved. That the better delivery system would make it an instant success. Or maybe not, maybe you still believe TrepT will take years to be successful.
If this 3 to 4 years till hockey stick results is such common knowledge then why didn't sny give afrezza the time ? Why didn't mnkd management tell investors its going to be years before we hit our stride with afrezza ?